Skip to content
drillr.ai
Sign up
ResearchBUD

[BUD] AB InBev Thesis 2026: Premium Brand Mix Tests EM Volume Recovery

Ddrillr ResearchOriginal research
Published 8 min read

Anheuser-Busch InBev SA/NV (NYSE: BUD) FY2025 revenue ~$60-62B (+0-3%) with adj. EBITDA ~$20-21B reflecting continued premium + super-premium brand mix expansion (~57%+ revenue from premium portfolio) plus selected post-2023 Bud Light controversy stabilization in US plus continued EM volume recovery (Mexico + Brazil + Africa + China) plus continued post-2016 SAB Miller deleveraging toward ~2.6-2.8x net leverage under continued CEO Michel Doukeris (~5-year tenure since July 2021). Global brewing leader with selected ~26%+ aggregate global beer market share + selected ~50%+ Latin America + ~40%+ Africa market share producing ~500+ beer brands globally. Founded 2008 via merger of InBev (Belgium-Brazilian brewing giant formed 2004 via InterBrew + AmBev merger) + Anheuser-Busch (US brewing giant founded 1852 St. Louis Missouri) creating selected ~$52B aggregate transaction; selected post-October 2016 ~$103B SAB Miller acquisition (selected largest brewing industry transaction ever) creating selected ~26%+ global beer market share leader. Earlier AmBev Brazil formed 1999 via Brahma + Antarctica merger; InterBrew Belgium founded 1366 (Den Hoorn brewery → Stella Artois 1366 Leuven); selected one of selected world's oldest continuing brewing operations. Headquartered in Leuven Belgium; ~158,000+ employees globally with ~$60-62B revenue. Five reporting segments: North America ~25% revenue (~$15B — Anheuser-Busch US + Labatt Canada; Bud Light + Budweiser + Michelob Ultra + Stella Artois + Corona import + selected craft brands), Middle Americas ~25% (~$15B — Mexico Modelo + Corona + Central America + Caribbean), South America ~25% (~$15B — Brazil AmBev + Argentina + Uruguay + Bolivia + Chile + Paraguay), EMEA ~15% (~$9B — Stella Artois Belgium + Hoegaarden + Becks Germany + selected African brewing), Asia Pacific ~10% (~$6B — China Budweiser + selected APAC). Premium portfolio leadership: ~57%+ revenue from Premium + Super-Premium brands FY2025 (vs ~50% FY2019); Megabrands (Corona + Stella Artois + Budweiser + Bud Light + Michelob Ultra + Modelo Especial) representing ~70%+ of revenue with ~+5-7% premium revenue growth FY2025 vs ~0-2% mainstream; Beyond Beer (Cutwater RTD + non-alcoholic + wellness beverages) ~3-5% revenue. US Bud Light recovery + Michelob Ultra: post-April 2023 Bud Light + Dylan Mulvaney social media controversy resulted in ~25-30% US Bud Light volume decline FY2023 (~$1.4B aggregate impact); FY2024-2025 stabilization at ~70% prior volume; Michelob Ultra became #1 US beer dollar share March 2024; FY2026 catalyst: continued US portfolio stabilization + Michelob Ultra growth + Modelo Especial market share. EM volume recovery: ~50%+ EM revenue exposure; Mexico Middle Americas (~25%) + Brazil South America (~20%) + Africa (~5%) + China (~5%); FY2026 catalyst: continued EM volume recovery + ~+3-5% aggregate EM volume growth. CEO Michel Doukeris since July 2021 (succeeded Carlos Brito CEO 2005-July 2021 retired who led ABI through 2008 InBev + Anheuser-Busch merger + 2016 SAB Miller acquisition; Doukeris ex-ABI Zone President North America 2018-July 2021 + ~30-year company career). Capital return: ~$0.81-0.85 annual dividend FY2025 (~€0.82/share); ~$2-3B annual buybacks (post-2024 buyback resumption); selected post-2024 net leverage ~2.6-2.8x (down from peak ~5x post-2016); investment-grade Baa1/BBB+ credit ratings. FY2026 thesis: premium portfolio mix expansion + US Bud Light recovery + EM volume rebound + continued deleveraging + buyback acceleration. Risks: macro consumer recession compress premium volume, US Bud Light continued stagnation, commodity inflation aluminum + barley + glass, EM currency depreciation Brazil real + Mexican peso, alcohol regulatory.

[BUD] AB InBev Thesis 2026: Premium Brand Mix Tests EM Volume Recovery

Key Takeaways

  • Anheuser-Busch InBev SA/NV (NYSE: BUD) FY2025 revenue ~$60-62B (+0-3% YoY) with adj. EBITDA ~$20-21B reflecting continued premium + super-premium brand mix expansion (~57%+ revenue from premium portfolio: Corona + Stella Artois + Michelob Ultra + selected craft + non-alcoholic premium) plus selected post-2023 Bud Light controversy stabilization in US plus continued EM volume recovery (Mexico + Brazil + Africa + China) under continued CEO Michel Doukeris (~5-year tenure since July 2021; ex-AB InBev Zone President North America 2018-July 2021 + ex-various ABI roles + ~30-year company career; succeeded Carlos Brito 2005-July 2021 retired who led ABI through SAB Miller acquisition).
  • Premium portfolio leadership: ~57%+ revenue from Premium + Super-Premium brands FY2025 (vs ~50% FY2019); Megabrands (Corona + Stella Artois + Budweiser + Bud Light + Michelob Ultra + Modelo Especial) representing ~70%+ of revenue with selected ~+5-7% premium revenue growth FY2025 vs ~0-2% mainstream.
  • US Bud Light recovery: post-April 2023 Bud Light + Dylan Mulvaney social media controversy resulted in ~25-30% US Bud Light volume decline FY2023; FY2024-2025 stabilization at ~70% prior volume + selected continued mix shift toward Michelob Ultra (became ~#1 US beer March 2024 surpassing Bud Light); FY2026 catalyst: continued US portfolio stabilization + Michelob Ultra growth.
  • Capital return: $0.81-0.85 annual dividend FY2025 (€0.82/share); selected ~$2-3B annual buybacks (post-2024 buyback resumption); selected post-2024 net leverage ~2.8x (down from peak ~5x post-2016 SAB Miller); investment-grade Baa1/BBB+ credit rating; FY2026 catalyst: continued deleveraging + dividend + buyback acceleration toward ~50% net income payout target.

Company Background

Anheuser-Busch InBev SA/NV (NYSE: BUD) is the global brewing leader with FY2025 revenue ~$60-62B (+0-3% YoY) and adj. EBITDA ~$20-21B reflecting continued premium + super-premium brand mix expansion (~57%+ revenue), post-2023 Bud Light controversy stabilization in US, and continued EM volume recovery in Mexico + Brazil + Africa + China. AB InBev produces ~500+ beer brands globally with ~26%+ aggregate global beer market share + selected ~50%+ Latin America + ~40%+ Africa market share. The company employs ~158,000+ globally with operations across ~50 countries.

Founded 2008 via merger of InBev (Belgium-Brazilian brewing giant formed 2004 via InterBrew + AmBev merger) + Anheuser-Busch (US brewing giant founded 1852 St. Louis Missouri) creating selected ~$52B aggregate transaction; selected post-October 2016 ~$103B SAB Miller acquisition (selected largest brewing industry transaction ever) creating selected ~26%+ global beer market share leader. Earlier AmBev Brazil formed 1999 via Brahma + Antarctica merger; InterBrew Belgium founded 1366 (Den Hoorn brewery → Stella Artois 1366 Leuven); selected one of selected world's oldest continuing brewing operations.

Headquartered in Leuven Belgium; ~158,000+ employees globally with ~$60-62B revenue. Five reporting segments: North America 25% revenue ($15B — Anheuser-Busch US + Labatt Canada; Bud Light + Budweiser + Michelob Ultra + Stella Artois + Corona import + selected craft brands), Middle Americas 25% ($15B — Mexico Modelo + Corona + selected Central America + Caribbean), South America 25% ($15B — Brazil AmBev + Argentina + Uruguay + Bolivia + Chile + Paraguay), Europe + Middle East + Africa 15% ($9B — selected European brewing including Stella Artois Belgium + Hoegaarden + Becks Germany + selected African brewing), Asia Pacific 10% ($6B — China Budweiser + selected APAC).

CEO Michel Doukeris since July 2021 (~5-year tenure); succeeded Carlos Brito (CEO 2005-July 2021 retired who led ABI through 2008 InBev + Anheuser-Busch merger + 2016 SAB Miller acquisition + selected ~$103B aggregate ABI deleveraging post-2016); Doukeris ex-ABI Zone President North America 2018-July 2021 + ex-ABI Zone President Asia Pacific 2014-2018 + ex-various ABI roles + ~30-year company career joining 1996 as sales trainee.

Premium Portfolio Leadership

AB InBev premium + super-premium portfolio represents selected ~57%+ revenue FY2025 (vs ~50% FY2019) reflecting continued premiumization shift:

  • Megabrands (~70%+ revenue): Corona + Stella Artois + Budweiser + Bud Light + Michelob Ultra + Modelo Especial + selected various international + premium local brands
  • Premium tier growth: ~+5-7% premium revenue growth FY2025 vs ~0-2% mainstream
  • Super-premium tier: Stella Artois + selected craft + non-alcoholic premium representing ~10-12% revenue with ~+8-10% growth
  • Beyond Beer: Cutwater + selected RTD cocktails + non-alcoholic + selected wellness beverages representing ~3-5% revenue

FY2026 catalyst: continued premium mix expansion toward ~60%+ revenue + Megabrands growth sustaining + ~$0.30-0.50 incremental annual EPS contribution.

US Bud Light Recovery + Michelob Ultra Cycle

Post-April 2023 Bud Light + Dylan Mulvaney social media controversy resulted in:

  • FY2023 impact: ~25-30% US Bud Light volume decline; ~$1.4B aggregate impact (volume + lost margin + marketing spend + special promotions + selected various recovery costs)
  • FY2024 stabilization: ~70% of pre-controversy volume sustained; selected continued Anheuser-Busch ABI North America segment EBITDA rebuilding
  • Michelob Ultra ascendance: became selected #1 US beer dollar share March 2024 surpassing Bud Light; selected continued Michelob Ultra ~10%+ growth FY2024-2025

FY2026 catalyst: continued Bud Light volume stabilization toward ~75-80% pre-controversy volume + Michelob Ultra continued growth + Modelo Especial market share gains + ~$0.20-0.40 incremental ABI North America EBITDA contribution.

EM Volume Recovery

AB InBev emerging market exposure ~50%+ of revenue:

  • Mexico Middle Americas: ~25% revenue; Modelo + Corona market share leadership; ~+3-5% volume growth FY2025
  • Brazil South America: ~20% revenue; AmBev Brahma + Skol + Antarctica + selected premium portfolio; ~+2-4% volume growth FY2025 post-COVID recovery
  • Africa: ~5% revenue; SAB Miller-acquired African operations including South Africa + Tanzania + Uganda + Nigeria; ~+5-8% volume growth FY2025
  • China: ~5% revenue; selected Budweiser + Harbin + selected craft; ~-3 to +1% volume FY2025 China consumer weakness

FY2026 catalyst: continued EM volume recovery + ~+3-5% aggregate EM volume growth + ~$0.20-0.40 incremental annual EPS contribution.

Risks

  • Macro consumer spending: macro recession could compress premium portfolio volume + mix expansion
  • US portfolio: continued Bud Light volume stagnation could compress ABI North America EBITDA recovery
  • Commodity inflation: aluminum + barley + glass + selected packaging cost inflation could compress gross margins
  • EM currency: Brazil real + Mexican peso + selected EM currency depreciation could compress USD-reported earnings
  • Regulatory: alcohol tax increases + selected health-related regulation could compress aggregate volume

Key Core Metrics

MetricFY2025FY2024FY2023FY2022FY2026 outlook
Revenue$60-62B$59.77B$59.38B$57.79B$61-64B
Adj. EBITDA$20-21B$20.99B$19.98B$19.84B$21-22B
Adj. EPS (USD)$3.30-3.65$3.13$2.93$2.78$3.55-3.95
Adj. EBITDA margin33-34%35.1%33.6%34.3%33-35%
Net leverage2.6-2.8x2.89x3.38x3.51x2.4-2.6x
Capital returnFY2025FY2024FY2026 outlook
Dividend$0.81-0.85 (€0.82)$0.83$0.85-0.92
Buybacks$2-3B$2.0B$2-3B
Total return$4-5B$3.6B$4-5B
Net leverage2.6-2.8x2.89x2.4-2.6x

Market Evaluation

AB InBev trades at selected ~14-16x FY2026 P/E discount vs Heineken (~18-20x) + Diageo (~18-22x) + Constellation Brands (~16-18x) reflecting selected post-2016 SAB Miller deleveraging continued (~2.6-2.8x net leverage vs ~5x peak) + post-2023 Bud Light controversy overhang + selected EM currency exposure ~50%+. Selected re-rating catalysts include: (1) continued premium portfolio mix expansion toward ~60%+; (2) US Bud Light volume stabilization + Michelob Ultra growth; (3) EM volume recovery in Mexico + Brazil + Africa; (4) continued deleveraging toward ~2.0-2.5x; (5) buyback + dividend acceleration toward ~50% net income payout.

Premium Portfolio Mix Expansion Deep Dive

AB InBev premium + super-premium portfolio ~57%+ FY2025 revenue (vs ~50% FY2019; ~45% FY2015) represents selected primary margin + EBITDA growth driver via mix shift away from mainstream commoditized beer toward higher-margin premium brands. Megabrands (Corona + Stella Artois + Budweiser + Bud Light + Michelob Ultra + Modelo Especial) representing ~70%+ revenue with selected ~+5-7% premium revenue growth FY2025 vs ~0-2% mainstream creating structural mix expansion. Corona + Modelo international expansion outside Mexico (Modelo Especial ~#3 US beer brand FY2024) drives ~+8-12% Modelo international volume growth. Selected Beyond Beer expansion including Cutwater RTD cocktails + selected non-alcoholic Budweiser Zero + Corona Sunbrew + selected wellness beverages represents ~3-5% revenue with ~+10-15% growth runway. FY2026 catalyst: continued premium mix expansion toward ~60%+ + Beyond Beer toward ~5%+ + ~$0.30-0.50 incremental annual EPS contribution from mix shift.

FY2026 thesis: premium portfolio mix expansion + US Bud Light recovery + EM volume rebound + continued deleveraging + buyback acceleration.

Companies in this article